Mutant MyoD Lacking Cdc2 Phosphorylation Sites Delays M-Phase Entry

Lionel A.J. Tintignac, Valentina Sirri, Marie Pierre Leibovitch, Yann Lécluse, Maria Castedo, Didier Metivier, Guido Kroemer, Serge A. Leibovitch

    Résultats de recherche: Contribution à un journalArticleRevue par des pairs

    36 Citations (Scopus)

    Résumé

    The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G2/M transition by controlling the expression of p21 Waf1/Cip1 (p21), which is believed to regulate cyclin B-Cdc2 kinase activity in G2. In growing myoblasts, MyoD reaccumulates during G2 concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G2 and delays M-phase entry. This G2 arrest is not observed in p21-/- cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G2/M transition.

    langue originaleAnglais
    Pages (de - à)1809-1821
    Nombre de pages13
    journalMolecular and Cellular Biology
    Volume24
    Numéro de publication4
    Les DOIs
    étatPublié - 1 févr. 2004

    Contient cette citation